Although still in it’s infancy, I’m happy to announce the successful launch of a new Rheumatology Journal Club on Twitter: #RheumJC. We just completed the our first online discussion of Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis and had a great turnout, with 519 tweets on the day of the journal club (summary available here). We thank the BMJ publishing group at the Annals of the Rheumatic Diseases for contributing to our success by making this article open access for our discussion.

The founding members of the #RheumJC team include Dr. Chris Collins (@RheumPearls), Dr. Suleman Bhana (@DrBhana), Dr. Aruni Jayatilleke (@rheumed), Dr. Jonathan Hausmann (@hausmannMD) and myself (@psufka).

We look forward to hosting further journal clubs on a regular basis.

Be sure to follow @RheumJC on Twitter and our blog at RheumJC.com.

If you would like to be involved in #RheumJC or have any other feedback or suggestions, please let us know via Twitter.